Found: 37
Select item for more details and to access through your institution.
Comparison of transcriptional responses between pathogenic and nonpathogenic hantavirus infections in Syrian hamsters using NanoString.
- Published in:
- PLoS Neglected Tropical Diseases, 2021, v. 15, n. 8, p. 1, doi. 10.1371/journal.pntd.0009592
- By:
- Publication type:
- Article
Glycoprotein-Specific Polyclonal Antibodies Targeting Machupo Virus Protect Guinea Pigs against Lethal Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 674, doi. 10.3390/vaccines12060674
- By:
- Publication type:
- Article
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 497, doi. 10.3390/vaccines12050497
- By:
- Publication type:
- Article
Improved DNA Vaccine Delivery with Needle-Free Injection Systems.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 280, doi. 10.3390/vaccines11020280
- By:
- Publication type:
- Article
SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071104
- By:
- Publication type:
- Article
Preclinical characterization of amubarvimab and romlusevimab, a pair of noncompeting neutralizing monoclonal antibody cocktail, against SARS-CoV-2.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.980435
- By:
- Publication type:
- Article
Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.
- Published in:
- PLoS Neglected Tropical Diseases, 2015, v. 9, n. 6, p. 1, doi. 10.1371/journal.pntd.0003803
- By:
- Publication type:
- Article
Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.
- Published in:
- PLoS Neglected Tropical Diseases, 2015, v. 9, n. 6, p. 1, doi. 10.1371/journal.pntd.0003803
- By:
- Publication type:
- Article
Humoral immunogenicity of a Coronavirus Disease 2019 (COVID-19) DNA vaccine in rhesus macaques (Macaca mulatta) delivered using needle-free jet injection.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0275082
- By:
- Publication type:
- Article
Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus.
- Published in:
- Nature Medicine, 2005, v. 11, n. 7, p. 740, doi. 10.1038/nm1261
- By:
- Publication type:
- Article
Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle.
- Published in:
- Scientific Reports, 2016, p. 24897, doi. 10.1038/srep24897
- By:
- Publication type:
- Article
Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0137786
- By:
- Publication type:
- Article
Side-by-Side Comparison of Gene-Based Smallpox Vaccine with MVA in Nonhuman Primates.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0042353
- By:
- Publication type:
- Article
DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS).
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035996
- By:
- Publication type:
- Article
Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Development of a specific MPXV antigen detection immunodiagnostic assay.
- Published in:
- Frontiers in Microbiology, 2023, p. 1, doi. 10.3389/fmicb.2023.1243523
- By:
- Publication type:
- Article
Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 6, p. 1, doi. 10.1371/journal.pntd.0006581
- By:
- Publication type:
- Article
A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters.
- Published in:
- PLoS Neglected Tropical Diseases, 2017, v. 11, n. 10, p. 1, doi. 10.1371/journal.pntd.0006042
- By:
- Publication type:
- Article
Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65059-0
- By:
- Publication type:
- Article
DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 264, p. 1, doi. 10.1126/scitranslmed.3010082
- By:
- Publication type:
- Article
Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 5, p. 1013, doi. 10.3390/v14051013
- By:
- Publication type:
- Article
Progress on the Prevention and Treatment of Hantavirus Disease.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 7, p. 610, doi. 10.3390/v11070610
- By:
- Publication type:
- Article
Human Polyclonal Antibodies Produced from Transchromosomal Bovine Provides Prophylactic and Therapeutic Protections Against Zika Virus Infection in STAT2 KO Syrian Hamsters.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 2, p. 92, doi. 10.3390/v11020092
- By:
- Publication type:
- Article
Ribavirin Protects Syrian Hamsters against Lethal Hantavirus Pulmonary Syndrome - After Intranasal Exposure to Andes Virus.
- Published in:
- Viruses (1999-4915), 2013, v. 5, n. 11, p. 2704, doi. 10.3390/v5112704
- By:
- Publication type:
- Article
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 4, p. 888, doi. 10.1093/cid/ciae215
- By:
- Publication type:
- Article
Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challenge.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00469-x
- By:
- Publication type:
- Article
Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-020-00279-z
- By:
- Publication type:
- Article
Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti- Andes orthohantavirus Neutralizing Antibodies in Patient Samples.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2020, v. 10, p. N.PAG, doi. 10.3389/fcimb.2020.00444
- By:
- Publication type:
- Article
Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216700
- By:
- Publication type:
- Article
Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 1, p. 30, doi. 10.1093/infdis/jiad235
- By:
- Publication type:
- Article
Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal Models.
- Published in:
- Frontiers in Microbiology, 2020, v. 11, p. 1, doi. 10.3389/fmicb.2020.00832
- By:
- Publication type:
- Article
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0196546
- By:
- Publication type:
- Article
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192312
- By:
- Publication type:
- Article